| 英文别名： |
D-cycloserine;CYCLOSERINE;D-CYCLOSERINE, STREPTOMYCES ORCHIDACEUS;D-4-AMINO-3-ISOXAZOLIDINONE;(R)-(+)-CYCLOSERINE;(R)-4-AMINO-ISOXAZOLIDIN-3-ONE;(R)-4-AMINO-3-ISOXAZOLIDINONE;R(+)-4-AMINO-3-ISOXAZOLIDINONE;(R)-4-AMINO-3-ISOXAZOLIDONE;SEROMYCIN;ORIENTOMYCIN;D-Cycoloserine;(R)-4-Aminoisoxazolidin-3-one;3-Isoxazolidinone,4-amino-, (4R)-;D-(+)-Cycloserine;106-7;3-keto-4,5-dihydro-isoxazolylamine;Closina;Cyclorin;E-733-A;I-1431;NJ-21;OXAMYCIN;Oxymycin;pa94;(R)-(+)-4-Amino-3-isoxazolidinone;Cyclo-D-serine;Wasserina;Farmiserina;Tisomycin;Cicloserina;Miroseryn;alpha-Cycloserine;(+)-4-Amino-3-isoxazolidinone;Miroserina;Cycloserinum;D-4-amino-3-isoxazolidone;Oxamicina;(4R)-4-aminoisoxazolidin-3-one;PA 94;(+)-Cycloserine;(4R)-4-amino-1,2-oxazolidin-3-one;Oxamicina [Italian];Cycloserin;Micoserina;Cicloserina [Italian];Tebemicina;Novoserin;D-Ox;AB00443920_09;HMS1571I20;Prestwick0_001089;Prestwick3_001089;UNII-95IK5KI84Z;SDCCGSBI-0050240.P005;LS-86757;Seromycin (TN);A836140;DivK1c_000098;AKOS015994626;MFCD00005353;Cycloserine (JP17/USP/INN);CYCLOSERINE [ORANGE BOOK];DCS;CYCLOSERINE (D);FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09;Tox21_500252;D-Cycloserine, >=96.0% (NT);NCGC00016306-07;SMP1_000167;KBio1_000098;IDI1_000098;NCGC00093713-02;EINECS 200-688-4;HY-B0030;3-Isoxazolidinone, 4-amino-, (4R)-;3-Isoxazolidinone, 4-amino-, (4R)- (9CI);Lopac-C-7005;.alpha.-Cycloserine;C-9400;Cycloserine (JP15/USP/INN);HMS500E20;D-Oxamicina;DTXCID902870;Prestwick1_001089;SR-01000075432-9;AB00443920;cycloserine;DB00260;R-(+)-Cycloserine;(R)-4-AMINOISOXAZOLIDIN-3-ONE;NCGC00016306-04;NCGC00016306-17;SCHEMBL34322;BPBio1_001252;NCGC00093713-01;CAS-339-72-0;CYCLOSERINUM [WHO-IP LATIN];HMS2232F03;4AX;CYCLOSERINE [MI];NCGC00015213-03;CYCLOSERINE [VANDF];Spectrum5_000797;(4R)-4-Amino-3-isoxazolidinone;DTXSID8022870;MLS000758215;3-Isoxazolidinone, 4-amino-, D;HMS1920C06;4-Amino-3-isoxazolidinone, (R)-;LMPK14000007;CHEBI:40009;C 3909;3-Isoxazolidinone, 4-amino-, (+)-(8CI);HMS3260D06;Spectrum4_000305;SC-49088;CAS-68-41-7;KBioGR_000890;NSC 154851;DRG-0195;SBI-0050240.P004;D02WFK;SPBio_003029;3-Isoxazolidinone, 4-amino-, d-;NSC-154851;Cicloserina [INN-Spanish];KBio2_001340;EN300-97131;D00877;SR-01000075432-1;3-Isoxazolidinone, 4-amino-, (+)- (8CI);NCGC00016306-08;NSC-756712;(R)-Cycloserine;Z1198154206;CYCLOSERINE [WHO-DD];NSC756712;HS-0079;Prestwick2_001089;SR-01000075432-5;NCGC00015213-01;BDBM50038178;HMS3259L19;Cycloserine [INN:BAN:JAN];Cycloserinum [INN-Latin];D-Cycloserine synth. BP 88;NCGC00260937-01;CYCLOSERINE [WHO-IP];CYCLOSERINE [INN];Tox21_110361;Cycloserine, D(+);s1998;EU-0100252;SR-01000759389;CYCLOSERINE [USP MONOGRAPH];SR-01000759389-4;Tox21_110361_1;(R)-4-Amino-3-isoxazolidinone;3-Isoxazolidinone, 4-amino-, (+)-;Lopac-C-1159;D-Oxamycin;1pb9;CYCLOSERINE [JAN];Cycloserine [BAN:INN:JAN];4-Amino-3-isoxazolidinone, D-;KBio2_003908;CCG-39705;LP00252;NC00050;Lopac0_000252... |
沪公网安备 
